Skip to content
  • Home
  • World News
  • Business
  • Aviation
  • Military
  • Lifestyle
  • Real Estate
  • Auto
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Military
  • Lifestyle
  • Real Estate
  • Auto
  • Toggle search form
  • Diane Herrick Stewart’s “Behind the Evergreens” is a gripping love story of couples who are in quest of their happiness. World News
  • GM, Ford, Stellantis And Toyota Urge Lifting EV Tax Credit Cap Aviation
  • NB Affordable Steps Up To Provide Resources And Relief To Jackson, MS Flood Victims Business
  • Automotive MEMS Sensor Market expanding at an impressive CAGR of 15% with valuation of US$ 9.75 Bn by 2032 Auto
  • QRT: Sports car ilegal na nakaparada, sinita ng clearing operations ng MMDA Auto
  • The Best Add-Ons for Real Estate Photography Real Estate
  • Nicole Benisti Collaborates With Nicola Peltz Beckham as Brand Ambassador for Fall/Winter 22 Business
  • Marcus Smart Partners With Signd Creating a Unique Memorabilia Experience for Celtic Fans Business

Pulmonary Arterial Hypertension Global Market To Grow At Rate Of 8% Through 2026

Posted on May 18, 2022June 30, 2022 By NewsEditor

Pulmonary Arterial Hypertension Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

The Business Research Company’s Pulmonary Arterial Hypertension Global Market Report 2022: Market Size, Trends, And Forecast To 2026

LONDON, GREATER LONDON, UK, May 18, 2022 /EINPresswire.com/ — According to ‘Pulmonary Arterial Hypertension Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026’ published by The Business Research Company, the pulmonary arterial hypertension market size is expected to reach $9.65 billion in 2026 at a CAGR of 8.22%. TBRC’s global coating additives market analysis shows that the increasing prevalence of pulmonary arterial hypertension (PAH) disease is contributing to the growth of the market.

Want to learn more on the pulmonary arterial hypertension market growth? Request for a Sample now.
https://www.thebusinessresearchcompany.com/sample.aspx?id=5954&type=smp

The pulmonary arterial hypertension market consists of sales of drugs by entities (organizations, sole proprietors, partnerships) that are used in the treatment of pulmonary arterial hypertension disease, which is a rare progressive disorder characterized by high blood pressure in the arteries of lungs. During this medical condition walls of the pulmonary arteries thicken and stiffen, making it difficult for the blood to flow through the lungs. The pulmonary arterial hypertension drugs relax the muscles in the wall of the blood vessels or increase the blood flow through the lungs or reverse the effect of the substance in the walls of blood vessels, which caused them to narrow.

Global Pulmonary Arterial Hypertension Market Trends
Technological advancements are key trends gaining popularity in the pulmonary arterial hypertension market. The companies operating in the pulmonary arterial hypertension drugs sector are focusing on developing new medicines to improvise and cure the diseases. In March 2019, Sandoz, a Switzerland-based company specializing in high-quality affordable medications announced the first fully substitutable AP-rated generic version of Remodulin treprostinil injection in the USA sold by United Therapeutics Corporation. Treprostinil Injection is used to reduce the symptoms of Pulmonary Arterial Hypertension and has the same active ingredient, strengths, dose form, and inactive ingredients as Remodulin® (treprostinil), and it is provided to patients and clinicians with the same level of service and support but at a lower cost.

Global Pulmonary Arterial Hypertension Market Segments
The global pulmonary arterial hypertension market is segmented:
By Drug Class: Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors, Prostacyclin and Prostacyclin Analogs, SGC Stimulators
By Route of Administration: Oral, Intravenous/ subcutaneous, Inhalational
By Distribution channel: Retail, Online
By Geography: The global pulmonary arterial hypertension market report is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America accounts for the largest share.

Read more on the global pulmonary arterial hypertension market report here
https://www.thebusinessresearchcompany.com/report/pulmonary-arterial-hypertension-global-market-report

Pulmonary Arterial Hypertension Global Market Report 2022 is one of a series of new reports from The Business Research Company that provides pulmonary arterial hypertension market overviews, analyzes and forecasts market size and growth for the global pulmonary arterial hypertension market, pulmonary arterial hypertension global market share, pulmonary arterial hypertension market segments and geographies, pulmonary arterial hypertension market players, pulmonary arterial hypertension market leading competitor revenues, profiles and market shares. The pulmonary arterial hypertension market report identifies top countries and segments for opportunities and strategies based on market trends and key competitors’ approaches.

TBRC’s Pulmonary Arterial Hypertension Global Market Report 2022 includes information on the following:

Data Segmentations: Market Size, Global, By Region and Country, Historic and Forecast, and Growth Rates for 60 Geographies

Key Market Players: United Therapeutics Corporation, Bayer AG, Gilead Sciences Inc., Johnson & Johnson, GlaxoSmithKline, Pfizer Inc., Sandoz AG, Lupin Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Acceleron Pharma Inc., Eli Lilly and Company, Actelion Pharmaceuticals US Inc, Natco Pharma Ltd, Zydus Pharmaceutical USA, and Liquidia Technologies Inc.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
And so much more.

Looking for something else? Here is a list of similar reports by The Business Research Company:
Anti-Hypertensive Drugs Global Market Report 2022 – By Therapeutics (Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators), By Disease Source (Primary Hypertension, Secondary Hypertension), By End Users (Hospitals, Clinics, Homecare) – Market Size, Trends, And Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report

Pulmonologists Global Market Report 2020 – By Practice (Owner-Solo Practice, Owner – Group Practice, Partner), By Disease (Chronic Obstructive Pulmonary Disease , Obstructive Sleep Apnea, Pulmonary Hypertension, Tuberculosis, Asthma And Allergy, Interstitial Lung Disease, Pneumonia, Lung Cancer, Cardio Pulmonary Disorders), COVID-19 Implications And Growth
https://www.thebusinessresearchcompany.com/report/pulmonologists-market-global-report-2020-2030-covid-19-implications-and-growth

Anticoagulants Global Market Report 2022 – By Drug Class (Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist), By Route Of Administration (Oral Anticoagulant, Injectable Anticoagulant), By Distribution Channel ( Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease ), By End User (Hospitals, Homecare, Specialty Centers )– Market Size, Trends, And Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/anticoagulant-global-market-report

About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Check out our:
LinkedIn: https://bit.ly/3b7850r
Twitter: https://bit.ly/3b1rmjS
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn

You just read:

News Provided By

May 18, 2022, 11:08 GMT


EIN Presswire’s priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content.
As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone’s Internet News Presswire™,
tries to define some of the boundaries that are reasonable in today’s world. Please see our
Editorial Guidelines
for more information.



Article originally published as: https://www.einpresswire.com/article/572923515/pulmonary-arterial-hypertension-global-market-to-grow-at-rate-of-8-through-2026

Business

Post navigation

Previous Post: Automotive Telematics Market is Booming Worldwide| Trimble Inc., AirIQ Inc., Actsoft, Verizon, Airbiquity Inc.
Next Post: Ed Rike Plumbing Is Now Offering Spring and Summer Servicing

Related Posts

  • NYC Manufacturing Mogul Launches Luxury Skincare Line, Balancé Business
  • ReoStar Signs LOI With L. Myers Associates for Acquisition Business
  • Pinpoint Communications Will Soon Cover Beatrice With Fiber to the Home Business
  • SCI 360 Announces Industry Advisory Board to Expand Financial Services Growth Business
  • Crenshaw: Uvalde law enforcement tactical response was ‘heartbreaking’ Business
  • Groundbreaking Ceremony Will Kick Off Construction of Sports Mecca in Delaware, Ohio Business
February 2023
MTWTFSS
 12345
6789101112
13141516171819
20212223242526
2728 
« Jan    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Secretary Antony J. Blinken and Israeli Foreign Minister Eli Cohen Before Their MeetingFebruary 2, 2023
  • Secretary Blinken’s Meeting with Israeli President HerzogFebruary 1, 2023
  • Acting Deputy Secretary Bass’s Meeting with Dutch MFA Secretary General HuijtsFebruary 1, 2023
  • Secretary Antony J. Blinken And Israeli Defense Minister Yoav Gallant Before Their MeetingFebruary 1, 2023
  • George Clooney’s Lifestyle 2021February 1, 2023
how to promote press release
VUGA Enterprises - media group PR & Marketing
  • Fidelity Life: 4 Reasons Millennials Should Consider Life Insurance During Inflation Lifestyle
  • How has Western aid for Ukraine’s military escalated amid Russia’s invasion? – BBC News Military
  • Watch Zelensky address joint meeting of Congress Aviation
  • Record-breaking digitizers get next variant Auto
  • Sober Safe Spot at Mardi Gras Returns to New Orleans Lifestyle
  • King Charles III makes first address to the UK as sovereign @BBC News – BBC World News
  • New Sporty Looking Cars that Are Actually Cheap? (Exterior and Interior Details) Auto
  • Brighthouse Financial deepens connection with Veteran-Owned Businesses by becoming a NVBDC Corporate Member. Military
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195News.

| Part of VUGA Media Group | Fair Use | Terms of Use | Get Published